dipyridamole has been researched along with Granulocytic Leukemia in 6 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cyclopentenyl cytosine (CPEC) is a carbocyclic cytidine analog inhibitor of CTP synthetase and experimental drug for combination chemotherapy." | 1.32 | CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase. ( Collins, M; Graves, LM; Huang, M; Wang, Y, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, M | 1 |
| Wang, Y | 1 |
| Collins, M | 1 |
| Graves, LM | 1 |
| Meschengieser, SS | 1 |
| Woods, AI | 1 |
| Schattner, MA | 1 |
| Lazzari, MA | 1 |
| Juranić, Z | 1 |
| Joksimović, J | 1 |
| Radulović, S | 1 |
| Juranić, I | 1 |
| Kuramoto, A | 1 |
| Taketomi, Y | 1 |
| Nakagawa, J | 1 |
| Uchino, H | 1 |
| Hirose, M | 1 |
| Takeda, E | 1 |
| Ninomiya, T | 1 |
| Kuroda, Y | 1 |
| Miyao, M | 1 |
| Chan, TC | 1 |
| Young, B | 1 |
| King, ME | 1 |
| Taetle, R | 1 |
| Howell, SB | 1 |
6 other studies available for dipyridamole and Granulocytic Leukemia
| Article | Year |
|---|---|
CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase.
Topics: Affinity Labels; Carbon-Nitrogen Ligases; Cell Differentiation; Cytidine; Cytidine Triphosphate; Dip | 2004 |
[Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
Topics: Adult; Aspirin; Blood Platelet Disorders; Dipyridamole; Female; Humans; Leukemia, Myeloid; Male; Mid | 1981 |
Adenosine contributes to the amine oxidase-mediated spermine cytotoxicity to human myelogenous leukemia K562 cells.
Topics: Adenosine; Adrenergic beta-Agonists; Albuterol; Aminophylline; Cardiotonic Agents; Cardiovascular Ag | 1998 |
Metabolic and kinetic study of thrombogenesis: regulatory mechanism in early step of platelet plug formation.
Topics: Adult; Aged; Blood Platelets; Dipyridamole; Epinephrine; Female; Glycolysis; Humans; Leukemia, Myelo | 1976 |
Synergistic inhibitory effects of dipyridamole and vincristine on the growth of human leukaemia and lymphoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Dipyridamole; Dose-Response Relati | 1987 |
Modulation of the activity of PALA by dipyridamole.
Topics: Animals; Aspartic Acid; Biological Transport; Cell Line; Colonic Neoplasms; Dipyridamole; Drug Inter | 1985 |